These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 24511525)
21. Meropenem-induced vanishing bile duct syndrome: A case report. Zubarev A; Haji K; Li M; Tiruvoipati R; Botha J J Int Med Res; 2020 Aug; 48(8):300060520937842. PubMed ID: 32865076 [TBL] [Abstract][Full Text] [Related]
22. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case. Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508 [TBL] [Abstract][Full Text] [Related]
23. Jaundice caused by the vanishing bile duct syndrome in a child with Hodgkin lymphoma. Yusuf MA; Elias E; Hübscher SG J Pediatr Hematol Oncol; 2000; 22(2):154-7. PubMed ID: 10779030 [TBL] [Abstract][Full Text] [Related]
25. A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen. Bak H; Kim H; Lee S; Lee Y; Bang SM; Lee YS Yonsei Med J; 2020 Dec; 61(12):1060-1063. PubMed ID: 33251781 [TBL] [Abstract][Full Text] [Related]
26. Enhanced biliary excretion of canalicular membrane enzymes in estrogen-induced and obstructive cholestasis, and effects of different bile acids in the isolated perfused rat liver. Accatino L; Figueroa C; Pizarro M; Solís N J Hepatol; 1995 Jun; 22(6):658-70. PubMed ID: 7560859 [TBL] [Abstract][Full Text] [Related]
27. Co-occurrence of cytomegalovirus-induced vanishing bile duct syndrome with papillary stenosis in HIV infection. Tyagi I; Puri AS; Sakhuja P; Majumdar K; Lunia M; Gondal R Hepatol Res; 2013 Mar; 43(3):311-4. PubMed ID: 23437911 [TBL] [Abstract][Full Text] [Related]
28. Improvement of vanishing bile duct syndrome with hyperlipidemia. Yamauchi R; Takata K; Fukunaga A; Tanaka T; Yokoyama K; Shakado S; Nabeshima K; Yoshimitsu K; Hirai F Clin J Gastroenterol; 2022 Aug; 15(4):784-790. PubMed ID: 35802301 [TBL] [Abstract][Full Text] [Related]
29. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma. Hubscher SG; Lumley MA; Elias E Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577 [TBL] [Abstract][Full Text] [Related]
30. [Spontaneous resolution of vanishing bile duct syndrome in Hodgkin's lymphoma]. Han WS; Jung ES; Kim YH; Kim CH; Park SC; Lee JY; Chang YJ; Yeon JE; Byun KS; Lee CH Korean J Hepatol; 2005 Jun; 11(2):164-8. PubMed ID: 15980675 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of serum gamma-glutamyl transpeptidase activity in liver diseases in children. Maggiore G; Bernard O; Hadchouel M; Lemonnier A; Alagille D J Pediatr Gastroenterol Nutr; 1991 Jan; 12(1):21-6. PubMed ID: 1676410 [TBL] [Abstract][Full Text] [Related]
32. [Vanishing bile duct syndrome following allogeneic bone marrow transplantation]. Aliani S; Meyer S; Krenn T; Müller-Molaian I; Graf N Klin Padiatr; 2002; 214(6):371-4. PubMed ID: 12424687 [TBL] [Abstract][Full Text] [Related]
33. Hepatic injury in a child caused by trimethoprim-sulfamethoxazole. Stevenson DK; Christie DL; Haas JE Pediatrics; 1978 Jun; 61(6):864-6. PubMed ID: 673549 [TBL] [Abstract][Full Text] [Related]
34. Mechanism of gamma-glutamyl transpeptidase release in serum during intrahepatic and extrahepatic cholestasis in the rat: a histochemical, biochemical and molecular approach. Bulle F; Mavier P; Zafrani ES; Preaux AM; Lescs MC; Siegrist S; Dhumeaux D; Guellaën G Hepatology; 1990 Apr; 11(4):545-50. PubMed ID: 1970323 [TBL] [Abstract][Full Text] [Related]
35. Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: A case report. Zhao Z; Bao L; Yu X; Zhu C; Xu J; Wang Y; Yin M; Li Y; Li W Medicine (Baltimore); 2017 Sep; 96(36):e8009. PubMed ID: 28885366 [TBL] [Abstract][Full Text] [Related]
36. Vanishing Bile Duct Syndrome in an Adult Patient: Case Report and Review of the Literature. Izzo P; Gallo G; Codacci Pisanelli M; D'Onghia G; Macci L; Gabriele R; Polistena A; Izzo L; Izzo S; Basso L J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743323 [TBL] [Abstract][Full Text] [Related]
37. Vanishing bile duct syndrome-related jaundice as the first presentation of Hodgkin lymphoma. Mellat-Ardakani M; Salahshour F; Rafsanjani K; Avanaki FA; Azizi M Radiol Case Rep; 2023 Sep; 18(9):3291-3294. PubMed ID: 37483375 [TBL] [Abstract][Full Text] [Related]
38. Vanishing Bile Duct Syndrome Associated With Non-Hodgkin's Lymphoma and Hepatitis E Virus Infection. Zafar M; Farooq M; Butler-Manuel W; Khattak MF; Rana UI; Muhammad T; Hawley I; Whitehead M; Toqeer M Cureus; 2022 Jan; 14(1):e21328. PubMed ID: 35070583 [TBL] [Abstract][Full Text] [Related]
39. Acute vanishing bile duct syndrome after the use of ibuprofen. Basturk A; Artan R; Yılmaz A; Gelen MT; Duman O Arab J Gastroenterol; 2016 Sep; 17(3):137-139. PubMed ID: 27658326 [TBL] [Abstract][Full Text] [Related]
40. Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis. Moradpour D; Altorfer J; Flury R; Greminger P; Meyenberger C; Jost R; Schmid M Hepatology; 1994 Dec; 20(6):1437-41. PubMed ID: 7982642 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]